Fig. 1. Pooled humoral response rates to SARS-CoV-2 primary vaccination series and additional doses in CAR-T recipients.
The Forest plot shows that the pooled humoral response rate was 28.2% (95%CI, 19.5-38.8%, I2=43%) among all 18 studies. The vaccine response rate among patients who only completed their primary vaccine series, without a third or a fourth dose, was 29.4% (95%CI, 19.4-41.8%, I2=50%) across 15 studies. After receiving a third or fourth vaccine dose, the pooled seroconversion rate was 24.3% (95%CI, 10.4-47%, I2=0%), reported in 4 studies (S7).
